InspireMD wins CE Mark approval for CGuard Prime
June 13, 2025
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke.
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke.
Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
The BiophysicaL Immune Profiling for Infants (BLIPI) profiles an infant’s immune system in under 15 minutes, using just a single drop of blood.